Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mengying Xing
Observed name:
Meng-Ying Xing
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
State Key Laboratory of Pharmaceutical Biotechnology,
Nanjing University
Observed institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
Jiangsu Province Hospital,
State Key Laboratory of Pharmaceutical Biotechnology,
Nanjing Medical University,
Nanjing University
show all 6
ORCID:
0000-0002-1752-1166
Observed ORCID:
0000-0002-1752-1166
OpenAlex ID:
A5049879667
Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
2025
·
Zhou Yang
, Wei Su
, et al.
·
Cancer Cell
·
234
m6A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis
2021
·
Jiashu Yang
, Ming Zhang
, et al.
·
Experimental & Molecular Medicine
·
79
PDF
PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer
2025
·
Shuang Qu
, Baijie Feng
, et al.
·
Oncogene
·
41
YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation
2022
·
Ming Zhang
, Jue Wang
, et al.
·
British Journal of Cancer
·
37
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?
2021
·
Mengying Xing
, Shichang Zhang
, et al.
·
Breast Care
·
37
NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis
2025
·
Qixiang Li
, Hongfei Ci
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
25
KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc
2024
·
Bing Yao
, Mengying Xing
, et al.
·
Clinical and Translational Medicine
·
25
TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
2022
·
Mengying Xing
, Ying Yang
, et al.
·
Genes & Genomics
·
22
EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN
2023
·
Bing Yao
, Mengying Xing
, et al.
·
Advanced Science
·
18
NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression
2024
·
Mengying Xing
, Bing Yao
, et al.
·
iScience
·
16
ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression
2023
·
Yuting Tang
, Yang Liu
, et al.
·
iScience
·
14
FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma
2023
·
Dongjun Yang
, Qixiang Li
, et al.
·
Journal of Biological Chemistry
·
7
PDF
An Unusual Cause of High Serum Prolactin
2020
·
Dan Wang
, Meng-Ying Xing
, et al.
·
Clinical Chemistry
·
7
ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways
2025
·
Jiaxuan Xu
, Xiaoqing Dong
, et al.
·
Advanced Science
·
6
Epidemiologic Features and Clinical Findings of COVID-19-Infected Patients in Suzhou
2020
·
Wentao Xu
, Shuang Qu
, et al.
·
SSRN Electronic Journal
·
5
Leveraging diverse cellular stress patterns for predicting clinical outcomes and therapeutic responses in patients with multiple myeloma
2024
·
Jiaxuan Xu
, Xiaoqing Dong
, et al.
·
Journal of Cellular and Molecular Medicine
·
2
A Panel of Platelet circRNAs Serve as Biomarker for Lung Cancer Detection
2020
·
Bing Yao
, Xin Yan
, et al.
·
SSRN Electronic Journal
·
1
Fibrillarin modulates fetal hemoglobin silencing
2024
·
Dongliang Wu
, Qixiang Li
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Identification and validation of glycolysis-related signatures for prognosis in patients with breast cancer
2020
·
Ming Zhang
, Mengying Xing
, et al.
PDF
Show more works
View as search
Works count:
19
Citation count:
576
H-index:
11
I10-index:
11
Year
Topic
Type